Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Clinical Decision Support Systems Market: By Component, By Product, By Type, By Delivery Mode, By Application and Region
Clinical Decision Support Systems Market: By Component, By Product, By Type, By Delivery Mode, By Application and Region
The global clinical decision market size was value US$ 1,838.9 million in 2023 and is projected to reach value of US$ 3,031.0 million by 2030, at a CAGR of 7.4% from 2024-2030. The market is the industry that provides healthcare IT systems to help physicians and clinical professionals make decisions. CDSSs can help improve patient care and operational efficiency by providing information and tools to help with clinical workflow.
The key drivers of CDSS market are increasing technological sophistication and the growing influence of social media, increasing adoption of mhealth tools & big data, growing rate of personalized medicine. However, some restraints which hamper the growth of CDSS market are concern about data quality, high cost of implementation and maintenance, privacy and security concerns. Additionally, the key opportunities of CDSS market are AI and machine learning technologies which offer immense potential for improving CDSS capabilities by enabling predictive analytics, risk stratification, and personalized treatment recommendations, increasing adoption of electronic health records. The key trends of CDSS are shift towards cloud-based solutions and Software-as-a-Service (SaaS) models, enhanced patient safety and error reduction.
The leading companies highlighted in the clinical decision support system market report include such as Cerner Corporation, Meditech, Epic Systems Corporation, Athenahealth Inc, Allscripts, Carestream, Agfa-Gevaert Group, Elsevier B.V., NextGen Healthcare Inc, Cerner Corporation, and others. Also, a comprehensive analysis of industry verticals and market participants that provides a clear overview of the competitive landscape in relation to the sectors served by the company’s products and services, market share, service offerings, financial reports, significant developments, market strategy, competitive position, and geographic reach.
By Component: The component segment has captured the largest share in clinical decision support system, due to its central role in powering the functionality, usability and scalability of CDSS. Because it runs the system's essential operations, interfaces with other healthcare IT systems, provides flexibility and scalability, and makes new technologies like artificial intelligence and machine learning possible, the software sector dominates the CDSS industry.
By Product: Among all the product types the standalone CDSS sub-segment is leading the market. A standalone clinical decision support system (CDSS) is a computerized system that provides clinical advice to healthcare providers without requiring standardization or extensive clinical expertise. Standalone CDSSs are popular because they are low cost, simple, and can operate without real patient data.
By Type: Among all the types, the clinical decision support system market was dominated by the therapeutic segment. This is due to the doctors usage of the technologies at a high rate and have the power to change clinical health practices by offering therapeutic best practices as an interface instead of only diagnostic help.
By Delivery Mode: The cloud-based segment is leading the market with largest share as, they don't rely on browsers, cloud-based apps are inherently more secure than their web-based counterparts. Cloud-based systems' processing nodes are located on remote computers, which could be spread across multiple data centres worldwide, due to the numerous benefits of cloud technologies, cloud-based CDSS use is anticipated to increase during the forecast period.
By Application: Among all the applications, drug allergy alerts segment is leading the market. Drug allergy alerts are a feature of CDSS that help prevent adverse drug events in healthcare settings. These alerts can warn clinicians of potential drug-allergy interactions, drug-drug interactions, or drug-disease warnings.
Study Period
2024-2030Base Year
2023CAGR
7.4%Largest Market
North AmericaFastest Growing Market
Asia Pacific
The increasing adoption of mHealth tools and big data is a significant driver in the growth of the Clinical Decision Support Systems (CDSS) market. Wearables, applications, and telemedicine platforms are examples of mHealth (mobile health) products that are frequently used for recording vital signs and remotely monitoring patients. Real-time health data, such as heart rate, blood sugar, physical activity, and medication adherence, are recorded by this technology. Healthcare practitioners can get insights for more individualised treatment recommendations by integrating the data gathered by mHealth tools with CDSS. For instance, a CDSS can be supplied data from a diabetic patient's wearable glucose monitor, and it can subsequently suggest adjusting the patient's insulin dosage.
The high cost of implementation and maintenance as well as privacy and security concerns are significant restraints to the growth of the market. A large investment in hardware, software, and infrastructure is needed to implement a CDSS. Integration with current hospital systems, such as electronic health records (EHRs), is also necessary. This is particularly difficult for medical facilities that are little or underfunded. It can be difficult and costly to integrate different hospital systems, EHRs, and medical devices, and maintenance costs, including hiring technical staff or third-party partners for support, can be a financial hardship.
AI and machine learning (ML) technologies present a tremendous opportunity for enhancing the capabilities of CDSS by enabling advanced predictive analytics. CDSS can assist healthcare practitioners in transitioning from reactive to proactive care by utilising predictive models. This entails identifying any health problems before they materialise to enable early intervention and individualised treatment regimens. Predictive analytics driven by AI can anticipate the course of an illness or its complications, allowing for prompt medical interventions that can greatly enhance patient outcomes.
Access to a wide range of media outlets is an emerging trend in CDSS market. For example, independent researchers' cloud-based Smart Clinical Decision Support System (Smart CDSS) now incorporates social media data collected for patients with chronic conditions. Clinical observations from real patient experiences are added to this data, this technology monitors the hobbies, health, and emotional state of patients based on their social media activity. The Smart CDSS then uses the data to generate recommendations that are specific to each patient.
Based on region analysis, the clinical decision support system market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. With a projected CAGR of 7.6% over the forecast period, North America is expected to maintain its position as the largest worldwide stakeholder in the clinical decision support systems market. The growing need for healthcare IT solutions in the medical business may be the reason for its dominance in the market. Asia pacific region is expected to grow significantly due to both the rapid advancement of technology and the increasing importance of providing high-quality healthcare services are driving market expansion in this sector. This can be attributed to countries like Australia, China, India, and Japan investing more on healthcare.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 1,838.9 million |
|
Market Size in 2030 |
US$ 3,031.0 million |
|
Market CAGR |
7.4% |
|
By Component |
|
|
By Product |
|
|
By Type |
|
|
By Delivery Mode |
|
|
By Application |
|
|
By Region |
|
CDSS is more important than ever due to the changing nature of modern medicine, which is marked by an abundance of patient data, a growing level of complexity in clinical decision-making, and an emphasis on personalised care. CDSS plays a critical role in facilitating contemporary healthcare by addressing the increasing complexity of clinical decision-making, promoting individualised treatment, and improving clinical effectiveness. The next major development in CDSS is the integration of AI and machine learning, which has enormous potential for predictive analytics and better patient outcomes. As healthcare continues to evolve, the necessity for sophisticated decision support systems like CDSS will become more pronounced
Download Free Sample Report
Clinical decision support systems size was valued US$ 1,838.9 million in 2023 set to reach at US$ 3,031.0 million by 2030, growing at a robust CAGR of 7.4%
• AI and machine learning technologies
• Risk stratification
• Personalized treatment recommendations
• Increasing adoption of electronic health records.
The key market players of clinical decision support systems market are Cerner Corporation, Meditech, Epic Systems Corporation, Athenahealth Inc, Allscripts.
Software segment is most widely used in clinical decision support systems market.
North America region is expected to dominate the clinical decision support systems market.
| 1.Executive Summary |
| 2.Global Clinical Decision Support Systems CDSS Market Introduction |
| 2.1.Global Clinical Decision Support Systems CDSS Market - Taxonomy |
| 2.2.Global Clinical Decision Support Systems CDSS Market - Definitions |
| 2.2.1.Component |
| 2.2.2.Type |
| 2.2.3.Product |
| 2.2.4.Application |
| 2.2.5.Region |
| 3.Global Clinical Decision Support Systems CDSS Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Clinical Decision Support Systems CDSS Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Clinical Decision Support Systems CDSS Market By Component , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Hardware |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Software |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Services |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6.Global Clinical Decision Support Systems CDSS Market By Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Therapeutic |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Diagnostic |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 7.Global Clinical Decision Support Systems CDSS Market By Product, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Integrated CDSS |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Standalone CDSS |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Others |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8.Global Clinical Decision Support Systems CDSS Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Drug Allergy Alerts |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Clinical Guidelines |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Drug-Drug Interactions |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Clinical Reminders |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Others |
| 8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.Global Clinical Decision Support Systems CDSS Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10.North America Clinical Decision Support Systems CDSS Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Component Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Hardware |
| 10.1.2.Software |
| 10.1.3.Services |
| 10.2. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Therapeutic |
| 10.2.2.Diagnostic |
| 10.3. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Integrated CDSS |
| 10.3.2.Standalone CDSS |
| 10.3.3.Others |
| 10.4. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Drug Allergy Alerts |
| 10.4.2.Clinical Guidelines |
| 10.4.3.Drug-Drug Interactions |
| 10.4.4.Clinical Reminders |
| 10.4.5.Others |
| 10.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11.Europe Clinical Decision Support Systems CDSS Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Component Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Hardware |
| 11.1.2.Software |
| 11.1.3.Services |
| 11.2. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Therapeutic |
| 11.2.2.Diagnostic |
| 11.3. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Integrated CDSS |
| 11.3.2.Standalone CDSS |
| 11.3.3.Others |
| 11.4. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Drug Allergy Alerts |
| 11.4.2.Clinical Guidelines |
| 11.4.3.Drug-Drug Interactions |
| 11.4.4.Clinical Reminders |
| 11.4.5.Others |
| 11.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 12.Asia Pacific (APAC) Clinical Decision Support Systems CDSS Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Component Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Hardware |
| 12.1.2.Software |
| 12.1.3.Services |
| 12.2. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Therapeutic |
| 12.2.2.Diagnostic |
| 12.3. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Integrated CDSS |
| 12.3.2.Standalone CDSS |
| 12.3.3.Others |
| 12.4. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Drug Allergy Alerts |
| 12.4.2.Clinical Guidelines |
| 12.4.3.Drug-Drug Interactions |
| 12.4.4.Clinical Reminders |
| 12.4.5.Others |
| 12.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13.Middle East and Africa (MEA) Clinical Decision Support Systems CDSS Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Component Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Hardware |
| 13.1.2.Software |
| 13.1.3.Services |
| 13.2. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Therapeutic |
| 13.2.2.Diagnostic |
| 13.3. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Integrated CDSS |
| 13.3.2.Standalone CDSS |
| 13.3.3.Others |
| 13.4. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Drug Allergy Alerts |
| 13.4.2.Clinical Guidelines |
| 13.4.3.Drug-Drug Interactions |
| 13.4.4.Clinical Reminders |
| 13.4.5.Others |
| 13.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14.Latin America Clinical Decision Support Systems CDSS Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 14.1. Component Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Hardware |
| 14.1.2.Software |
| 14.1.3.Services |
| 14.2. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Therapeutic |
| 14.2.2.Diagnostic |
| 14.3. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Integrated CDSS |
| 14.3.2.Standalone CDSS |
| 14.3.3.Others |
| 14.4. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Drug Allergy Alerts |
| 14.4.2.Clinical Guidelines |
| 14.4.3.Drug-Drug Interactions |
| 14.4.4.Clinical Reminders |
| 14.4.5.Others |
| 14.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Cerner Corporation |
| 15.2.2.Meditech |
| 15.2.3.Epic Systems Corporation |
| 15.2.4.Athenahealth Inc |
| 15.2.5.Allscripts |
| 15.2.6.Carestream |
| 15.2.7.Agfa-Gevaert Group |
| 15.2.8.Elsevier B.V. |
| 15.2.9.NextGen Healthcare Inc |
| 15.2.10.Cerner Corporation |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.